Volume 26, Number 10—October 2020
Research Letter
Eliminating Spiked Bovine Spongiform Encephalopathy Agent Activity from Heparin
Table
Sample | Animal bioassay |
RT-QuIC |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Samples with heparin |
Samples after heparin removed |
Samples after heparin removed |
|||||||||
log10 ID50/g brain | log10 removal |
log10 ID50/g brain | log10 removal |
log10 SD50/g brain | log10 removal |
||||||
Step | Total | Step | Total | Step | Total | ||||||
BSE spike | 8.0 | NA | NA | 6.9 | NA | NA | 9.0 ± 0.2 | NA | NA | ||
NaOH treatment | 6.3 | 1.7 | 1.7 | 5.4 | 1.5 | 1.5 | 6.6 ± 0.3 | 2.4 | 2.4 | ||
DE filtration | <5.2 | >1.1 | >2.8 | <4.0 | >1.4 | >2.9 | 5.3 ± 0.1 | 1.3 | 3.7 | ||
H2O2 bleaching | ND | NA | NA | <3.4 | >0.6 | >3.5 | 5.0 ± 0.4 | 0.3 | 4.0 | ||
Final product | ND | NA | NA | <2.6 | >0.8 | >4.3 | 5.0 ± 0.6 | 0.0 | 4.0 |
*Values are the number of animals with confirmed BSE divided by the number of animals inoculated. BSE, bovine spongiform encephalopathy; DE diatomaceous earth; H2O2, hydrogen peroxide; ID50, 50% infectious dose; NA, not applicable; NaOH, sodium hydroxide; ND, not detectable; NT, not tested; RT-QuIC, real-time quaking-induced conversion; SD50, 50% seeding dose; TSE, transmissible spongiform encephalopathies.
Page created: July 16, 2020
Page updated: September 17, 2020
Page reviewed: September 17, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.